AI assistant
Sending…
Fulgent Genetics, Inc. — Director's Dealing 2020
Aug 6, 2020
32553_dirs_2020-08-05_e3696bc5-7bee-4714-88e0-b6baf867cec6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Fulgent Genetics, Inc. (FLGT)
CIK: 0001674930
Period of Report: 2020-08-03
Reporting Person: KIM PAUL (CFO and Treasurer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-08-03 | Common Stock | A | 40000 | $0.00 | Acquired | 473813 | Direct |
Footnotes
F1: Reflects an award of restricted stock units relating to 40,000 shares of the Issuer's common stock. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after August 15, 2020, and 1/16th of such shares vesting every three months over the remaining 36 months, subject to the reporting person's continued service for Issuer on each vesting date.
More from Fulgent Genetics, Inc.
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 14
Proxy Solicitation & Information Statement
2026
Mar 31
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Annual Report
2026
Feb 27
Regulatory Filings
2026
Feb 27
Director's Dealing
2026
Feb 26